CFI-400945
CFI-400945 is a potent, ATP-competitive inhibitor of PLK4 (Polo-like kinase 4) (Ki = 0.2 nM). Displays anticancer properties. PLK4 inhibition also prevents cell division and inhibits proliferation of PLK4-overexpressing tumor cells.
Product Specifications
Shipping Conditions
gel pack
Storage Conditions
-20°C
Shelf Life
36 months
More Discoveries
Explore Other Products
Browse additional items from our catalog
031224-ML650 100 µL
RPS6KA3 (RPS6KA3, ISPK1, MAPKAPK1B, RSK2, Ribosomal protein S6 kinase alpha-3, 90kD ribosomal protein S6 kinase 3, Insulin-stimulated protein kinase 1, MAP kinase-activated protein kinase 1b, Ribosomal S6 kinase 2, pp90RSK2) (MaxLight 650) discontinued
Sign In for Pricing
View Details ELI-17879b 96 Tests
Bovine UBX domain-containing protein 4, UBXN4 ELISA KIT
Sign In for Pricing
View Details 
35-1013-100 100 µL
Polyclonal Antibody to NF-KB-p65 (Phospho-Ser536)
Sign In for Pricing
View Details